Hippocampal electrophysiological responses and changes in oxidative stress marker and serum lipid profile to pharmacological and non-pharmacological treatments of high-fat-fructose diet induced metabolic syndrome

Open access

Abstract

The aim of our study was to evaluate the possibility of influencing the risk factors of metabolic syndrome (MetS) and metabolic cognitive syndrome. As a model of MetS, we used high-fat-fructose diet (HFFD) fed hypertriacylglycerolemic (HTG) rats. Control group included HTG rats fed with HFFD during 8 weeks (HFFD8). Furthermore, we tested the effect of pharmacological and non-pharmacological therapies. Non-pharmacological therapy, which we chose, was a change in diet from HFFD (5 weeks) to standard one (3 weeks) and thus caloric restriction (HFFD5+3). The drug we used was rosmarinic acid (RA; 100mg/kg), which we administered to rats after 5 weeks of HFFD once a day for consecutive 3 weeks with current change in diet to standard one (HFFD5+3+RA) or during lasting last 3 weeks of HFFD (HFFD8+RA). After 8 weeks of experiment, lipid peroxidation markers, lipid profile of blood serum, and neuronal transmission and synaptic plasticity (long-term potentiation [LTP]) in hippocampal sections were evaluated in vitro. We observed a significant effect of dietary change in lipid profile (decreased total cholesterol and low-density lipoprotein cholesterol [LDL-cholesterol] and increased high-density lipoprotein cholesterol [HDL-cholesterol]). The combination of pharmacological and non-pharmacological treatments caused a decrease in total cholesterol, LDL-cholesterol, and lipid peroxidation in blood serum. Change in HFFD to standard diet without treatment resulted in slight improvement in neuronal transmission in the hippocampus and caloric restriction alone also had positive effect on LTP maintenance. Our results suggest that combination of pharmacological and non-pharmacological approaches had better impact on the biochemical parameters of MetS in blood serum, but weak impact on neuronal functions in the hippocampus, where the expected positive effect was achieved only by caloric restriction.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Al-Sarraj T Saadi H Volek JS Fernandez ML: Carbohydrate restriction favorably alters lipoprotein metabolism in Emirati subjects classified with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 201020(10):720-726.

  • [2] Al-Sereiti MR Abu-Amer KM Sen P: Pharmacology of Rosemary (Rosmarinus officinalis Linn.) and Its Therapeutic Potentials. Indian J Exp Biol. 1999 37:124-130.

  • [3] Bhatt R Mishra N Bansal PK: Phytochemical pharmacological and pharmacokinetics effects of rosmarinic acid. JPSI. 2013 2(2):28-34.

  • [4] Bi S Robinson BM and Moran TH. Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression. Am J Physiol Regul Integr Comp Physiol 2003 285:1030-36.

  • [5] Cull-Candy S Kelly L Farrant M: Regulation of Ca2þ-permeable AMPA receptors: synaptic plasticity and beyond Curr. Opin. Neurobiol. 2006 16:288-297.

  • [6] Decressac M Barker RA. Neuropeptide Y and its role in CNS disease and repair. Exp Neurol. 2012 238:265-272.

  • [7] Drapper HH Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990 186:421–431.

  • [8] Fadel O El Kirat K Morandat S: The natural antioxidant rosmarinic acid spontaneously penetrates membranes to inhibit lipid peroxidation in situ. Biochim Biophys Acta. 2011 1808:2973–2980.

  • [9] Fale PLV Madeira PJA Florencio MH Ascensao L Serralheiro MLM: Function of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitor. Food & Function. 2011; 2: 130-136.

  • [10] Ferrini F Salio C Lossi L Merighi A. Ghrelin in central neurons. Curr Neuropharmacol. 2009 7:37-49.

  • [11] Frisardi V Solfrizzi V Seripa D Capurso C Santamato A Sancarlo D Vendemiale G Pilotto A Panza F: Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer’s disease. Ageing Res Rev 1. 2010; 9:399–417.

  • [12] Govindaraj J Sorimuthu Pillai S: Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: Streptozotocin-induced diabetic rats. Mol Cell Biochem. 2015 404:143–159.

  • [13] Grundy SM Barlow CE Farrell SW Vega GL Haskell WL: Cardiorespiratory fitness and metabolic risk. Am J Cardiol 2012 109:988-993.

  • [14] Kishi T Hiroka Y Nagayama T Isegawa K Katsuki M Takesue K Sungawa K: Calorie restriction improves cognitive decline via upregulation of brain-derived neurotrophic factor. Int Heart J. 2014 56(1):110-115.

  • [15] Kuo Y-Ch Rajesh R: Targeted delivery of rosmarinic acid across the blood–brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E. Int J Pharm. 2017 528:228–241.

  • [16] Matsuo M Gomi F Kuramoto K Sagai M: Food restriction suppresses an age-dependent increase in the exhalation rate of pentane from rats: a longitudinal study. J. Gerontol. 1993 48(4):B133–136.

  • [17] Minor RK Chang JW de Cabo R: Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction. Mol Cell Endocrinol. 2009 299:79-88.

  • [18] Morris RG: Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5 J Neurosci. 1989 9:3040-3057.

  • [19] Nikhra V: Revisiting Caloric Restriction as Therapeutic Strategy for Metabolic Syndrome T2DM and Obesity. IOD. 2018 2(3):1-5.

  • [20] Osakabe N Yasuda A Natsume M Yoshikawa T: Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis. 2004 25:549-557.

  • [21] Pettersen M Simmonds MSJ: Rosmarinic acid. Phytochemistry. 2013 12:207-227.

  • [22] Ristow M Schmeisser K: Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response. 2014 12(2):288–341.

  • [23] Sasaki K El Omri A Kondo S Han J Isoda H: Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation Behav Brain Res. 2013 238:86-94.

  • [24] Spencer SJ Miller AA Andrews ZB. The role of ghrelin in neuroprotection after ischemic brain injury. Brain Sci. 2013 3:344-59.

  • [25] Stoeckel LE Arvanitakis Z Gandy S Small D Pascual-Leone A Pawlyk A Shewrin R Smith P: Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. Version 2. F1000Res. 2016; 5:353.

  • [26] Ueda H Yamazaki C Yamazaki M: Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion. Biol Pharm Bull. 2003; 26:560-563.

  • [27] Volek JS Phinney SD Forsythe CE Quann EE Wood RJ Puglisi MJ Kreamer WJ Bibus DM Fernandez ML Feinman RD: Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009 44:297–309.

  • [28] Yan FX Yan T: Effect of rosmarinic acid against the PC12 cell injures induced by glutamate Acta Pharmacol. Sin. 2006 27:100.

Search
Journal information
Impact Factor


CiteScore 2018: 0.39

SCImago Journal Rank (SJR) 2018: 0.128
Source Normalized Impact per Paper (SNIP) 2018: 0.337

Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 25 25 10
PDF Downloads 29 29 14